Sign in
4

Changes in Ownership

Gain Therapeutics, Inc. Filed Acc 0001641172-25-016540

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Riley Jeffrey Scott Director 2025-06-24 Grant or award · Stock Option (right to buy) +15,000 15,000 D
Loading xslF345X05/ownership.xml…